Revance Therapeutics, Inc.

Nashville, Tennessee, United States revance.com

Overview

Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product known as DaxibotulinumtoxinA. The company aims to redefine patient and physician competencies in the field of neuromodulation.

Therapeutic areas

AestheticsNeurology

FDA compliance signals

1 FDA enforcement record linked to this company.

  • 4832025-02-27

    Scientifically sound laboratory controls

Related companies

Merz Pharmaceuticals GmbH
Germany
3D Imaging Drug Design and Development LLC
United States
A&B Pharmaceuticals
United States
ABC Biopharmaceuticals, Inc.
United States
ABX Pharmaceuticals Inc.
USA
AC Biotech Incorporated
USA
Accendatech USA Inc.
United States
ActiPharma Incorporated
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo